Related Experiment Video
Updated: May 8, 2026

09:46
Robotic Heller Myotomy for Advancements in Surgical Management of Achalasia
Published on: February 16, 2024
Postoperative outcomes after robotic versus abdominal myomectomy
Leanne Griffin1, Joe Feinglass, Ariane Garrett
1Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
JSLS : Journal of the Society of Laparoendoscopic Surgeons
|September 11, 2013
Summary
Robotic-assisted laparoscopic myomectomy (RALM) offers quicker recovery than abdominal myomectomy (AM) but results in larger residual fibroid volume. Both procedures effectively reduce fibroid symptoms and improve patient satisfaction.
Area of Science:
- Minimally Invasive Surgery
- Gynecologic Oncology
- Surgical Outcomes
Background:
- Robotic-assisted laparoscopic myomectomy (RALM) and abdominal myomectomy (AM) are surgical options for uterine fibroids.
- Limited data exist on comparative postoperative outcomes between RALM and AM.
Purpose of the Study:
- To compare surgical outcomes, quality of life, and residual fibroid burden after RALM versus AM.
- To evaluate patient recovery and satisfaction following each surgical approach.
Main Methods:
- A comparative study of consecutive patients undergoing RALM (n=16) and AM (n=23) for uterine fibroids (<20 weeks size).
- Surgical outcomes were extracted from medical records.
- Quality of life and residual fibroid volume were assessed via telephone interviews at 6 weeks and ultrasonography at 12 weeks post-surgery.
Main Results:
- RALM involved longer operative times (261.1 min vs 124.8 min) and lower operative efficiency.
- RALM patients experienced shorter hospital stays (1.5 days vs 2.7 days) and faster return to work (85.7% vs 45.0%).
- Residual fibroid volume was significantly greater in the RALM group (17.3 cm³ vs 3.4 cm³).
Conclusions:
- Both RALM and AM are equally effective in improving patient symptoms and overall satisfaction.
- RALM facilitates a quicker patient recovery with shorter hospital stays and faster return to work.
- A significantly larger residual fibroid burden is observed 12 weeks after RALM compared to AM.
